高度血清性卵巢癌的向治疗:文学综述
Kaitlyn Dinkins1, Wade Barton1, Lauren Wheeler2
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL.
Gynecologic oncology reports
|August 2, 2024
概括
高度血清性卵巢癌的预后很差,原因是治疗耐药性. 本综述探讨了超越传统化疗的新型向疗法,包括PARP抑制剂和新兴药物,以改善卵巢癌治疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 卵巢癌,特别是高度血清性卵巢癌 (HGSOC),具有很高的死亡率.
- 像手术和基于的化疗等传统治疗方法经常遇到阻力.
- 最近的进展包括PARP抑制剂和抗血管生成剂,但其他向疗法表现出有限的成功.
研究的目的:
- 审查针对高度血清性卵巢癌的向治疗方法.
- 涵盖从临床前研究到临床试验的治疗策略.
主要方法:
- 临床前研究和临床试验的文献综述.
- 讨论各种向治疗类别.
主要成果:
- 抗性仍然是卵巢癌治疗的一个重大挑战.
- PARP 抑制剂和贝瓦西祖马布已经影响了前期治疗.
- 免疫疗法尚未在卵巢癌中取得类似的成功.
结论:
- 新兴的向疗法,包括小分子氨酸激酶抑制剂和脂质代谢剂正在研究中.
- 基因疗法和针对核糖体的药物代表了其他有前途的治疗途径.
- 对新的向治疗方法的持续研究对于推进HGSOC治疗至关重要.
更多相关视频
14:25Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
17.4K
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010
18.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K